Client News
Filter by:
- Apr 18 2022 ASHFORD ANNOUNCES ACQUISITION OF CHESAPEAKE HOSPITALITY TO ACCELERATE GROWTH OF ITS HOTEL MANAGEMENT BUSINESS
- Jan 6 2022 Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
- Jan 4 2022 Arch Therapeutics Announces Appointment of Guy Fish to the Board
- Dec 30 2021 Pingtan Marine Enterprise Receives Extension from Nasdaq to meet Bid Price Requirement
- Dec 29 2021 Pingtan Marine Enterprise Announces Results of Annual General Meeting
- Dec 20 2021 Pingtan Marine Enterprise to Hold Annual General Meeting of Members on December 23, 2021
- Dec 17 2021 OncoSec Announces Changes to its Board of Directors
- Dec 14 2021 INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18
- Dec 13 2021 Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
- Dec 1 2021 Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program